RecruitingPhase 3NCT05561114
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
Sponsor
GIE Medical
Enrollment
198 participants
Start Date
Dec 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
To evaluate the safety and efficacy of the ProTractX3™ DCB for the treatment of benign esophageal strictures.
Eligibility
Min Age: 22 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Control and GIE Medical ProTractX3 TTS DCB for people with esophageal stricture. The study is currently recruiting participants at 34 locations. People eligible for this study include aged 22 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
COMBINATION_PRODUCTGIE Medical ProTractX3 TTS DCB
Paclitaxel Coated Balloon
OTHERControl
Standard Endoscopic Dilation
Locations(34)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05561114